Bratislava, Slovakia

Martina Takacova

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mabpro A.s.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martina Takacova. Retrieved from https://idiyas.com/inventor/martina-takacova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martina Takacova: Innovator in Antibody Development

Introduction

Martina Takacova is a prominent inventor based in Bratislava, Slovakia. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work is crucial in advancing therapeutic options for various diseases.

Latest Patents

Martina holds a patent titled "Humanized Anti-CA IX Antibodies and Methods of Their Use." This patent represents her innovative approach to creating antibodies that can target specific cancer markers, enhancing treatment efficacy.

Career Highlights

Martina is currently employed at Mabpro A.S., where she continues to push the boundaries of antibody research. Her dedication to her work has positioned her as a key player in the biotechnology sector.

Collaborations

She collaborates with notable colleagues, including Silvia Pastorekova and Jaromir Pastorek, who contribute to her research efforts and enhance the impact of her work.

Conclusion

Martina Takacova's contributions to antibody development exemplify her commitment to innovation in biotechnology. Her patent and ongoing research are paving the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…